Next Article in Journal / Special Issue
Physical and Oxidative Stability of Uncoated and Chitosan-Coated Liposomes Containing Grape Seed Extract
Previous Article in Journal / Special Issue
Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
Review

New Transfection Agents Based on Liposomes Containing Biosurfactant MEL-A

School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan
*
Author to whom correspondence should be addressed.
Pharmaceutics 2013, 5(3), 411-420; https://doi.org/10.3390/pharmaceutics5030411
Received: 27 June 2013 / Revised: 29 July 2013 / Accepted: 8 August 2013 / Published: 16 August 2013
(This article belongs to the Special Issue Liposome Technologies)
Nano vectors are useful tools to deliver foreign DNAs, oligonucleotides, and small interfering double-stranded RNAs (siRNAs) into mammalian cells with gene transfection and gene regulation. In such experiments we have found the liposomes with a biosurfacant mannosylerythriol lipid (MEL-A) are useful because of their high transfer efficiency, and their unique mechanism to transfer genes to target cells with the lowest toxicity. In the present review we will describe our current work, which may contribute to the great advance of gene transfer to target cells and gene regulations. For more than two decades, the liposome technologies have changed dramatically and various methods have been proposed in the fields of biochemistry, cell biology, biotechnology, and so on. In addition, they were towards to pharmaceutics and clinical applications. The liposome technologies were expected to use gene therapy, however, they have not reached a requested goal as of yet. In the present paper we would like to present an approach using a biosurfactant, MEL-A, which is a surface-active compound produced by microorganisms growing on water-insoluble substrates and increases efficiency in gene transfection. The present work shows new transfection agents based on liposomes containing biosurfactant MEL-A. View Full-Text
Keywords: biosurfactant; cationic liposome; membrane fusion; siRNA; CLSM biosurfactant; cationic liposome; membrane fusion; siRNA; CLSM
Show Figures

Figure 1

MDPI and ACS Style

Nakanishi, M.; Inoh, Y.; Furuno, T. New Transfection Agents Based on Liposomes Containing Biosurfactant MEL-A. Pharmaceutics 2013, 5, 411-420. https://doi.org/10.3390/pharmaceutics5030411

AMA Style

Nakanishi M, Inoh Y, Furuno T. New Transfection Agents Based on Liposomes Containing Biosurfactant MEL-A. Pharmaceutics. 2013; 5(3):411-420. https://doi.org/10.3390/pharmaceutics5030411

Chicago/Turabian Style

Nakanishi, Mamoru, Yoshikazu Inoh, and Tadahide Furuno. 2013. "New Transfection Agents Based on Liposomes Containing Biosurfactant MEL-A" Pharmaceutics 5, no. 3: 411-420. https://doi.org/10.3390/pharmaceutics5030411

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop